Alerts will be sent to your verified email
Verify Email
ZIMLAB
|
Zim Laboratories
|
Gennex Lab
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
11.0 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
7.41 % | 7.82 % | -23.88 % |
|
5yr average Equity Multiplier
|
1.88 | 1.53 | 1.78 |
|
5yr Average Asset Turnover Ratio
|
0.94 | 0.75 | 0.6 |
|
5yr Avg Net Profit Margin
|
4.15 % | 7.88 % | -23.79 % |
|
Price to Book
|
1.32 | 1.85 | 3.66 |
|
P/E
|
35.38 | 20.61 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
37.07 Days | 43.23 Days | -10.34 Days |
|
Inventory Days
|
68.72 Days | 49.12 Days | 93.5 Days |
|
Days Receivable
|
99.71 Days | 50.53 Days | 66.75 Days |
|
Days Payable
|
143.26 Days | 75.36 Days | 179.8 Days |
|
5yr Average Interest Coverage Ratio
|
3.96 | 6.21 | -11.84 |
|
5yr Avg ROCE
|
13.52 % | 11.17 % | -15.03 % |
|
5yr Avg Operating Profit Margin
|
12.21 % | 10.47 % | -13.23 % |
|
5 yr average Debt to Equity
|
0.39 | 0.18 | 0.21 |
|
5yr CAGR Net Profit
|
10.7 % | 43.63 % | 0.22 % |
|
5yr Average Return on Assets
|
4.02 % | 5.16 % | -14.62 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
33.26 % | 19.83 % | 52.62 % |
|
Share Pledged by Promoters
|
0.0 | 21.79 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -2.22 % | -13.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 9.9 % |
|
Zim Laboratories
|
Gennex Lab
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Capex
|
Capex
|
-
|
-
|
|
Customer Segment
|
Customer Segment
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|